Woburn-based Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. Founded by Chris Loose, David L. Lucchino, Jeff Karp, and Will McLean in 2015, Frequency Therapeutics is backed by investors that include Alexandria Real Estate Equities, Alexandria Venture Investments, Korea Investment Partners, Morningside Group, and Taiwania Capital.
FOUNDED:
2015
INDUSTRY:
Biotechnology, Genetics, Medical
FOUNDERS:
Chris Loose, David L. Lucchino, Jeff Karp, Will McLean
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
